AU6840894A - Hormonal means for acne therapy and employment thereof - Google Patents
Hormonal means for acne therapy and employment thereofInfo
- Publication number
- AU6840894A AU6840894A AU68408/94A AU6840894A AU6840894A AU 6840894 A AU6840894 A AU 6840894A AU 68408/94 A AU68408/94 A AU 68408/94A AU 6840894 A AU6840894 A AU 6840894A AU 6840894 A AU6840894 A AU 6840894A
- Authority
- AU
- Australia
- Prior art keywords
- hormonal
- hormone
- daily units
- component
- hormone component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003054 hormonal effect Effects 0.000 title abstract 5
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract 2
- 206010000496 acne Diseases 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000005556 hormone Substances 0.000 abstract 5
- 229940088597 hormone Drugs 0.000 abstract 5
- 239000000262 estrogen Substances 0.000 abstract 2
- 229940125697 hormonal agent Drugs 0.000 abstract 2
- 238000004806 packaging method and process Methods 0.000 abstract 2
- 101600111816 Homo sapiens Sex hormone-binding globulin (isoform 1) Proteins 0.000 abstract 1
- 102300044179 Sex hormone-binding globulin isoform 1 Human genes 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000002280 anti-androgenic effect Effects 0.000 abstract 1
- 239000000051 antiandrogen Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A hormonal agent for the treatment of acne with two spatially separated hormonal components fitted separately in a packaging unit and intended for administration sequentially in time, consisting of a number of hormonal daily units arranged spatially separately in and individually removable from the packaging unit, a first hormonal component essentially containing as the hormonal active agent only an oestrogen preparation causing an increase in the sex hormone-binding globulin (SHBG) and the second hormone component containing an oestrogen and an anti-androgen preparation in combination, characterized in that the total number of daily units is equal to the total number of days in the desired cycle, in that the first hormone component comprises 5 to 14 and the second hormone component 23 to 14 daily units, and in that the number of daily units of the first hormone component is smaller than that of the second hormone component. The invention also concerns the use of this hormonal agent.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4321957 | 1993-07-01 | ||
| DE4321957A DE4321957C2 (en) | 1993-07-01 | 1993-07-01 | Use of a hormonal agent to treat acne |
| PCT/DE1994/000629 WO1995001180A1 (en) | 1993-07-01 | 1994-06-03 | Hormonal agent for the treatment of acne and its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6840894A true AU6840894A (en) | 1995-01-24 |
| AU695894B2 AU695894B2 (en) | 1998-08-27 |
Family
ID=6491735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU68408/94A Ceased AU695894B2 (en) | 1993-07-01 | 1994-06-03 | Hormonal means for acne therapy and employment thereof |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0710111B1 (en) |
| JP (1) | JPH09500112A (en) |
| AT (1) | ATE205716T1 (en) |
| AU (1) | AU695894B2 (en) |
| BR (1) | BR9407340A (en) |
| CA (1) | CA2166121A1 (en) |
| DE (2) | DE4321957C2 (en) |
| DK (1) | DK0710111T3 (en) |
| ES (1) | ES2164103T3 (en) |
| HU (1) | HUT73234A (en) |
| NO (1) | NO308586B1 (en) |
| PT (1) | PT710111E (en) |
| UA (1) | UA43337C2 (en) |
| WO (1) | WO1995001180A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19534209A1 (en) * | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonal agent for the treatment of the skin |
| CA2316303A1 (en) * | 1997-12-26 | 1999-07-08 | Masaki Nakamura | Suppressing agent of angiogenesis, containing dienogest as effective ingredient |
| DE102004026670A1 (en) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate |
| DE102004026671A1 (en) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Dosage form for hormonal contraception |
| DE102004026679A1 (en) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate |
| DE102006003508A1 (en) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Medicament comprising a hormone combination |
| DE102006003509A1 (en) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | contraceptive |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU565915B2 (en) * | 1982-12-31 | 1987-10-01 | Mortimer, C.H. | Pharmaceutical composition of antibiotic and anti- androgen |
| DE3442857A1 (en) * | 1984-11-22 | 1986-05-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Composition for the treatment of androgenisation symptoms in women |
| DE3916112A1 (en) * | 1989-05-16 | 1990-11-22 | Schering Ag | DIHYDROSPIRORENONE AS AN ANTIANDROGEN |
| DE4104385C1 (en) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich |
-
1993
- 1993-07-01 DE DE4321957A patent/DE4321957C2/en not_active Expired - Lifetime
-
1994
- 1994-06-03 CA CA002166121A patent/CA2166121A1/en not_active Abandoned
- 1994-06-03 BR BR9407340A patent/BR9407340A/en not_active Application Discontinuation
- 1994-06-03 UA UA95125308A patent/UA43337C2/en unknown
- 1994-06-03 AT AT94916880T patent/ATE205716T1/en not_active IP Right Cessation
- 1994-06-03 JP JP7503202A patent/JPH09500112A/en active Pending
- 1994-06-03 AU AU68408/94A patent/AU695894B2/en not_active Ceased
- 1994-06-03 EP EP94916880A patent/EP0710111B1/en not_active Expired - Lifetime
- 1994-06-03 WO PCT/DE1994/000629 patent/WO1995001180A1/en not_active Ceased
- 1994-06-03 DK DK94916880T patent/DK0710111T3/en active
- 1994-06-03 PT PT94916880T patent/PT710111E/en unknown
- 1994-06-03 DE DE59409869T patent/DE59409869D1/en not_active Expired - Fee Related
- 1994-06-03 ES ES94916880T patent/ES2164103T3/en not_active Expired - Lifetime
- 1994-06-03 HU HU9503770A patent/HUT73234A/en unknown
-
1995
- 1995-12-29 NO NO955347A patent/NO308586B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO955347D0 (en) | 1995-12-29 |
| DK0710111T3 (en) | 2001-12-10 |
| PT710111E (en) | 2002-02-28 |
| DE4321957C2 (en) | 1995-09-28 |
| EP0710111A1 (en) | 1996-05-08 |
| DE59409869D1 (en) | 2001-10-25 |
| NO308586B1 (en) | 2000-10-02 |
| NO955347L (en) | 1995-12-29 |
| WO1995001180A1 (en) | 1995-01-12 |
| EP0710111B1 (en) | 2001-09-19 |
| HUT73234A (en) | 1996-07-29 |
| CA2166121A1 (en) | 1995-01-12 |
| AU695894B2 (en) | 1998-08-27 |
| HU9503770D0 (en) | 1996-02-28 |
| ATE205716T1 (en) | 2001-10-15 |
| DE4321957A1 (en) | 1995-01-12 |
| JPH09500112A (en) | 1997-01-07 |
| BR9407340A (en) | 1996-10-08 |
| ES2164103T3 (en) | 2002-02-16 |
| UA43337C2 (en) | 2001-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1062595A (en) | Means and method for hormonal contraception and/or acne treatment | |
| DE69432752D1 (en) | COMPOSITION FOR SUBSTITUTION THERAPY THAT CONTAINS AT LEAST ONE PROGESTOGEN AND AT LEAST ONE OESTROGEN | |
| CA2045885A1 (en) | Inhibition of mammalian muscle wasting and protein degradation by tetracyclines | |
| NZ308293A (en) | Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids | |
| TW429152B (en) | A tretinoin aqueous gel composition for therapeutic topical administration to the skin | |
| AU1255002A (en) | Delayed-release pharmaceutical formulations | |
| MX9703354A (en) | Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids. | |
| PL312219A1 (en) | Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids | |
| UA41401C2 (en) | Pharmaceutical combined contraceptive agent | |
| MY106938A (en) | Method of treating premature ejaculation using sertraline | |
| CA2124531A1 (en) | Retinoid composition | |
| EP0663835A1 (en) | Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy. | |
| AU695894B2 (en) | Hormonal means for acne therapy and employment thereof | |
| AU1191795A (en) | Deuterated active substances in transdermal application | |
| MX9702381A (en) | Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies. | |
| GR3023828T3 (en) | Compositions for treatment of the hair. | |
| AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
| MX9709684A (en) | Use of vitamin d4 derivatives for treating skin disorders. | |
| UA19504A (en) | Agent for treatment of the skin and hypodermic cellular tissue purulent inflammations | |
| IT1269827B (en) | Lidocaine bicarbonate, its pharmaceutical use and compositions containing it | |
| MX9800697A (en) | Use of calendula glycosides for the treatment of psoriasis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |